Skip to content

Wave Life Sciences WVE Increase (Decrease) in Prepaid Expense

Increase (Decrease) in Prepaid Expense at other companies

MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+9.2%
Enterprise value$615.92M-27.2%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's increase (decrease) in prepaid expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's increase (decrease) in prepaid expense?
Wave Life Sciences (WVE) reported increase (decrease) in prepaid expense of $4.83M in Q1 2026.
How has Wave Life Sciences's increase (decrease) in prepaid expense changed year-over-year?
Wave Life Sciences's increase (decrease) in prepaid expense increased by 425.9% year-over-year, from -$1.48M to $4.83M.
What is the long-term trend for Wave Life Sciences's increase (decrease) in prepaid expense?
Over 2 years (2021 to 2024), Wave Life Sciences's increase (decrease) in prepaid expense has grown at a -69.1% compound annual growth rate (CAGR), from -$3.85M to -$368K.